Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Quest Diagnostics Inc. buy melinda

Quest Diagnostics Inc.
Start price
€96.95
30.01.18 / 50%
Target price
€99.22
11.06.18
Performance (%)
2.86%
End price
€99.27
11.06.18
Summary
This prediction ended on 11.06.18 with a price of €99.27. The BUY prediction by melinda finished with a performance of 2.86%. melinda has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Quest Diagnostics Inc. -3.475% -3.475% 7.293% 32.986%
iShares Core DAX® -3,52 % -4,99 % 1,93 % 50,82 %
iShares Nasdaq 100 0,26 % 1,10 % 15,43 % 90,84 %
iShares Nikkei 225® -4,95 % -3,35 % 29,01 % 51,21 %
iShares S&P 500 -0,82 % -0,04 % 10,81 % 62,94 %

Comments by melinda for this prediction

In the thread Quest Diagnostics Inc. diskutieren
Prediction Buy
Perf. (%) 2.86%
Target price 99.220
Change
Ends at 11.06.18

SecteurInstallations und Dienstleistungen im Gesundheitswesen Agenda 01/02 | 00.45 Ergebnisse Veröffentlichung



Beruf
Logo Quest Diagnostics
Quest Diagnostics ist der erste globale Anbieter von diagnostischen Tests und Informationsdienste für Patienten und medizinisches Fachpersonal. Der Umsatz ist Aktivität gliedern sich wie folgt:
- Diagnose-Tests (95%);
- andere (5%).

Anzahl der Mitarbeiter: 43.000 Menschen.



melinda 
0
Report Share
30.01.18
Prediction Buy
Perf. (%) 2.86%
Target price 99.220
Change
Ends at 11.06.18

(Zielkurs erreicht)

melinda 
0
Report Share
11.06.18

Stopped prediction by melinda for Quest Diagnostics Inc.

buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€82.50
09.04.20
€100.00
04.11.21
51.15%
05.11.21

melinda 
09.04.20 50%
buy
Quest Diagnostics Inc.

Start price
Target price
Perf. (%)
€79.24
02.12.18
€87.04
22.01.19
-1.16%
22.01.19

melinda 
18.08.19 50%